Close

Add to pipeline

Save Close
You are viewing a limited version of this profile. To access i3's full capabilities.
BlueNalu
Save
Company logo (jpg or png)
Parent company
Edit alternate names

Short description

Developer of cultivated seafood products

Founded in 2017
Founded in

Company type Private Public ()
Company type

Industry Group agriculture & food

Sector alternative proteins

TRL Range 4-6
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters San Diego, CA San Diego, United States
Address
City
State
Zip
Country

Parent Companies

Website

Updated by at on 10/16/2023

Edited by Cleantech Group on 11/26/2024

Traction
  • 0 M&A items
tags
Similar companies
Customers
Save
Add Customer
Date Company
Partnerships
Save
Add Partnership
Date Partner Type
09/13/2021
Nomad Foods Nomad Foods
Nomad Foods, Europe’s leading frozen food company, and BlueNalu,2 a leading innovative food company developing a variety of seafood products directly from fish cells, have agreed to explore the introduction of cell-cultured seafood in Europe, where demand for sustainably produced, healthy seafood products continues to grow.
View source    
Confirmed by Nomad Foods
Channel Partner
Delete
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Cancel Save
Add Investment
Date Investors Type Amount
10/09/2023 Agronomics Agronomics (1)
Post-money valuation of
The funding from "new and existing investors" (most as yet undisclosed) will enable scaling and commericialization, with BlueNalu planning to launch its first commercial product, premium bluefin tuna toro, following regulatory approval. This deal means Agronomics has invested $8 million in total across BlueNalu's Seed, Series A, and pre-Series B convertible rounds, giving it a 5.12% equity stake.
 Series B $33,500,000
Delete
Click to add IPO information
Products
Save
Add Product
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font